Lenzing Draws Roughly 30 Suitors for Heiligenkreuz as Post-Rights-Issue Register Settles
Published on 11/03/2026 at 13:01 | Editorial boerse-global.de
Lenzing's textile fibre plant in Heiligenkreuz will keep producing until the end of March 2027, with the bidding phase for the site's sale due to open in November, according to Friday media reports. The twin disclosures give investors both a production horizon and the next milestone in the divestment process — a timetable that now runs alongside the group's freshly redrawn share register.
The capital increase completed roughly two weeks ago raised gross proceeds of about EUR 301.2 million. Share capital now stands at EUR 76,204,702.90, spread across 73,374,542 shares, figures Lenzing published in a correction to its voting rights notification tied to the rights issue. Syndicate members took up 18,159,291 new shares in total. Georg Kasperkovitz also reported a purchase under the subscription rights offering, acquiring 16,362 Lenzing shares at EUR 8.65 apiece.
Ownership has shifted accordingly. The syndicate of B&C-Gruppe and Suzano S.A. holds around 52.25% of voting rights, a combined majority that survived the transaction intact. Suzano Holding S.A. picked up an additional 0.80% of Lenzing stock directly, while Goldman Sachs Group reported a 5.86% stake.
Deutsche Bank Halves Its Target
Deutsche Bank Research cut its price target for Lenzing to EUR 12.70 from EUR 22.00, confirming its "Hold" rating. The adjustment, dated 28 October, cited the capital increase as its reference point. The stock gained 1.9% in the prior session to close at EUR 11.00 — below the newly lowered target.
Should investors sell immediately? Or is it worth buying Lenzing?
That revision frames the debate ahead of the next hard data point. Lenzing has scheduled publication of its third-quarter 2026 results for 5 November 2026. Until then, the question for investors is whether to position for a convincing operating performance or to wait for verified figures.
Financing Is Not Earnings
The distinction matters because a completed capital raise and a viable business are separate valuation questions; the first cannot substitute for the second. The proceeds are a concrete financing figure, not an operating profit, and say nothing on their own about whether the current business has improved or whether future earnings will hold up.
The quarterly report will therefore be judged chiefly on what the earnings trend implies for the wider business. A single strong number would carry less weight than a coherent overall picture. What counts is whether results justify a more favourable view — not merely the fact that fresh capital has been raised.
The shareholder structure offers a supporting stability argument but no substitute for hard figures. A continuing majority speaks to voting rights, not to future income. Anyone buying before the results is betting on an operating signal that has yet to arrive.
Two Paths From Here
In the brighter scenario, operating results give investors reason to rate Lenzing's prospects more highly, letting the capital measure serve as a supportive framework rather than the entire investment case. Business performance and financing would then point the same way, reinforced by the syndicate's continued 52.25% grip and Suzano Holding's direct 0.80% position.
Lenzing at a turning point? This analysis reveals what investors need to know now.
The darker path is a quarterly report that offers insufficient evidence of better earnings. Attention would swing quickly from the fundraising back to operating capability, and the cautious assessment would gain further weight. The confirmed "Hold" was neither a buy nor a sell call, and it should not be read as a statement that the financing success pre-empts an operating improvement.
Either way, the Heiligenkreuz sale process and the 5 November results date now give the market two concrete catalysts to weigh. The capital increase alone does not settle that choice.
Ad
Lenzing Stock: New Analysis - 3 November
Fresh Lenzing information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.
